View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AN58 | Publication ID: Fall 2006 |
Title: Medicare Part B Competitive Acquisition of Outpatient Drugs and Biologicals (CMS-1325-F) | |
Abstract: Section 303(d) of the Medicare Modernization Act requires the implementation of a competitive bidding program for Medicare Part B drugs not paid on a cost or prospective payment system basis. Beginning July 1, 2006, physicians will be given a choice between purchasing these drugs and being paid by Medicare under the average sales price (ASP) system, or obtaining these drugs from vendors selected in a competitive bidding process. If the physician elects to obtain drugs from a competitive vendor, the vendor will bill Medicare for the drug. | |
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Long-Term Actions |
Major: No | Unfunded Mandates: No |
CFR Citation: 42 CFR 414 | |
Legal Authority: MMA of 2003, sec 303(d) |
Legal Deadline:
|
||||||||||||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Yes | Government Levels Affected: None |
Small Entities Affected: Businesses | Federalism: No |
Included in the Regulatory Plan: No | |
Agency Contact: Corinne Axelrod Health Insurance Specialist, Hospital and Ambulatory Policy Group Department of Health and Human Services Centers for Medicare & Medicaid Services Mailstop C5-14-03, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-5620 Email: corinne.axelrod@cms.hhs.gov |